The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome

he Cholesteryl Ester Transfer Protein (CETP) aqIB Polymorphism in the Cholesterol nd Recurrent Events Study: o Interaction With the Response to Pravastatin herapy and No Effects on Cardiovascular Outcome Prospective Analysis of the CETP TaqIB olymorphism on Cardiovascular Outcome and nteraction With Cholesterol-Lowering Therapy reetje J. de Grooth, MD, PHD,* Kim E. Zerba, PHD,† Shu-Pang Huang, PHD,† Zenta Tsuchihashi, PHD, odd Kirchgessner, PHD,† René Belder, MD,† Priya Vishnupad, BSC,† Beihong Hu, MSC,† nke H. E. M. Klerkx, PHD,* Aeilko H. Zwinderman, PHD,‡ J. Wouter Jukema, MD, PHD,§ rank M. Sacks, MD, PHD, John J. P. Kastelein, MD, PHD,* Jan Albert Kuivenhoven, PHD* msterdam and Leiden, The Netherlands; Princeton, New Jersey; and Boston, Massachusetts